Focus on trimetazidine in acute coronary syndrome
نویسندگان
چکیده
منابع مشابه
Trimetazidine effects on cardiac biomarkers in acute coronary syndrome
Trimetazidine acts at the cellular level, increasing myocardial glucose oxidation and shifting substrate utilization from fatty acid to carbohydrate metabolism. In an ischemic situation, this promotes the formation of adenosine triphosphate, the main source of cardiac energy, at less oxygen cost. The benefit on myocyte necrosis can be judged by reduction in release of biomarkers such as cardiac...
متن کاملAcute Coronary Syndrome: Focus on Antiplatelet Therapy.
The American Heart Association/American College of Cardiology in 2014 published a focused update of the 2007 and 2012 guidelines for non-ST-segment elevation acute coronary syndrome (NSTE-ACS). The management of ST-segment elevation myocardial infarction (STEMI) is described in a separate guideline published in 2013. The focused updates to the guidelines contain updated recommendations for dual...
متن کاملcost benefits of rehabilitation after acute coronary syndrome in iran; using an epidemiological model
چکیده ندارد.
Effect of trimetazidine on heart rate variability in elderly patients with acute coronary syndrome.
BACKGROUND AND OBJECTIVE Trimetazidine has mainly been used in coronary insufficiency, angina and elderly myocardial infarction. However, the effect of trimetazidine on the efficacy, heart rate variability (HRV) and protection of myocardial ischemia in elderly patients with acute coronary syndrome (ACS) remains unclear. This study aimed to investigate the effect of trimetazidine on the efficacy...
متن کاملPercutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin
Previously, indirect thrombin inhibitors such as unfractionated heparin or low-molecular-weight heparin were used as a standard anticoagulation during percutaneous coronary intervention to prevent procedural thrombotic complications but at a risk of hemorrhagic complications. More recently, bivalirudin, a member of the direct thrombin inhibitor class, has been shown to have 1) predictable pharm...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Heart and Metabolism
سال: 2018
ISSN: 1566-0338
DOI: 10.31887/hm.2018.75/gowdak